Rare diseases
Investigational molecules
Locations
Back to France3 332 clinical trials in Corbeil Essonnes, France across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in FranceEssaisCliniques.fr(opens in a new tab)Study of Entrectinib for Patients with Advanced or Metastatic Solid Tumors with Specific Gene Changes
FranceStudy on the Effectiveness and Safety of Cevostamab and Tocilizumab for Patients with Relapsed or Refractory Multiple Myeloma
FranceStudy on EO4010 Vaccine with Nivolumab and Bevacizumab for Patients with Metastatic Colorectal Cancer Who Have Already Received Treatment
FranceStudy Comparing Talquetamab, Daratumumab, and Pomalidomide with Drug Combination for Patients with Relapsed or Refractory Multiple Myeloma
FranceStudy on the Effectiveness and Safety of Olorofim vs. Liposomal Amphotericin B for Patients with Invasive Aspergillosis
FranceStudy on Vimseltinib for Patients with Tenosynovial Giant Cell Tumor
FranceStudy Comparing Doxycycline and Benzathine Benzylpenicillin for Treating Early Syphilis in Adults
FranceStudy of Belzutifan and Palbociclib for Patients with Advanced Renal Cell Carcinoma
FranceStudy on the Safety of Doravirine and Islatravir for HIV Patients Who Previously Participated in Doravirine/Islatravir Trials
FranceStudy of Pembrolizumab for Patients with Early Stage Non-Small Cell Lung Cancer After Surgery and Standard Therapy
FranceStudy Comparing Teclistamab with Pomalidomide, Bortezomib, and Dexamethasone for Patients with Relapsed or Refractory Multiple Myeloma After 1-3 Prior Treatments
FranceStudy of Teclistamab and Lenalidomide as Maintenance Treatment for Newly Diagnosed Multiple Myeloma Patients After Stem Cell Transplantation
FranceThe busiest research cities in the country
What the registry says about research in the country
Clinical research focusing on novel treatments for Type 1 and Type 2 Diabetes, particularly investigating therapies like tirzepatide for glycemic control and cardiovascular outcomes in patients with obesity and diabetes.
Groundbreaking trials in Multiple Myeloma treatment, evaluating combinations of targeted therapies including elranatamab, lenalidomide, and daratumumab for newly diagnosed and relapsed cases.
Research examining innovative treatments for Immune Thrombocytopenia, Polymyalgia Rheumatica, and Lupus Nephritis, focusing on targeted therapies and steroid-sparing approaches.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
